{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:51:48Z","timestamp":1762005108303,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ymgme.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:47:43Z","timestamp":1557337663000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs"],"prefix":"10.1016","volume":"128","author":[{"given":"Susi","family":"Anheuser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Breiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Sandhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.04.007_bb0005","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","article-title":"Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis","volume":"33","author":"Sandhoff","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1432-1033.1982.tb19789.x","article-title":"Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2","volume":"123","author":"Conzelmann","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1515\/bchm2.1979.360.2.1837","article-title":"Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A","volume":"360","author":"Conzelmann","year":"1979","journal-title":"Hoppe Seylers Z Physiol. Chem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0020","doi-asserted-by":"crossref","first-page":"24246","DOI":"10.1074\/jbc.270.41.24246","article-title":"Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein","volume":"270","author":"Li","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0076-6879(03)01055-3","article-title":"Interaction of GM2 activator protein with glycosphingolipids","volume":"363","author":"Li","year":"2003","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1432-1033.2003.03964.x","article-title":"Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation","volume":"271","author":"Wendeler","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0035","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1194\/jlr.M061036","article-title":"Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity","volume":"56","author":"Anheuser","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1022526407855","article-title":"Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay","volume":"24","author":"Bierfreund","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-8552-4_5","article-title":"Ganglioside metabolism and its inherited diseases","volume":"1804","author":"Breiden","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0050","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1002\/1873-3468.13114","article-title":"Emerging concepts of ganglioside metabolism","volume":"592","author":"Sandhoff","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0055","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/glycob\/cwv091","article-title":"Symbol nomenclature for graphical representations of Glycans","volume":"25","author":"Varki","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0060","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s11064-010-0380-3","article-title":"Secondary alterations of sphingolipid metabolism in lysosomal storage diseases","volume":"36","author":"Prinetti","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2760(83)90218-7","article-title":"Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen","volume":"750","author":"Vanier","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","article-title":"Niemann-Pick diseases","volume":"113","author":"Vanier","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0075","series-title":"JIMD Reports","first-page":"15","article-title":"Chondroitin 6-sulfate as a novel biomarker for mucopolysaccharidosis IVA and VII","volume":"16","author":"Shimada","year":"2014"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0080","series-title":"Handbook of Neurochemistry","first-page":"17","article-title":"Neurochemical aspects of mucopolysaccharidoses","author":"Suzuki","year":"1972"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/bchm3.1994.375.7.447","article-title":"The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts","volume":"375","author":"Hurwitz","year":"1994","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0014-5793(04)00033-X","article-title":"Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine","volume":"559","author":"K\u00f6lzer","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1194\/jlr.M073510","article-title":"Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal beta-glucocerebrosidase","volume":"58","author":"Abdul-Hammed","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-1033.1986.tb10071.x","article-title":"Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system","volume":"160","author":"Sarmientos","year":"1986","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0105","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M092551","article-title":"Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles","author":"Anheuser","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0076-6879(87)38028-0","article-title":"Lysogangliosides: synthesis and use in preparing labeled gangliosides","volume":"138","author":"Schwarzmann","year":"1987","journal-title":"Methods Enzymol."},{"year":"1999","series-title":"Strukturuntersuchungen an \u00df-Hexosaminidase B und GM2-Aktivatorprotein durch proteinchemische Methoden und MALDI-Massenspektrometrie","author":"Sch\u00fctte","key":"10.1016\/j.ymgme.2019.04.007_bb0115"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1515\/bchm2.1977.358.2.779","article-title":"Specificity of human liver hexosaminidases A and B against glycosphingolipids GM2 and GA2. Purification of the enzymes by affinity chromatography employing specific elution","volume":"358","author":"Sandhoff","year":"1977","journal-title":"Hoppe Seylers Z Physiol. Chem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0005-2736(91)90295-J","article-title":"Small-volume extrusion apparatus for preparation of large, unilamellar vesicles","volume":"1061","author":"MacDonald","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10719-009-9273-6","article-title":"Glycosaminoglycans from earthworms (Eisenia andrei)","volume":"27","author":"Im","year":"2010","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0135","series-title":"Gums and Stabilisers for the Food Industry","first-page":"15","article-title":"Polysaccharide molecular weight determination: which technique?","volume":"4","author":"Hardig","year":"1988"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(66)80341-4","article-title":"Hurler\u2019s syndrome","volume":"69","author":"Blattner","year":"1966","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0145","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2016.04.002","article-title":"N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice","volume":"118","author":"Kaidonis","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0065-2660(01)44078-8","article-title":"Biosynthesis of normal and mutant beta-hexosaminidases","volume":"44","author":"Neufeld","year":"2001","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0160","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1074\/jbc.M110.192062","article-title":"Secondary storage of dermatan sulfate in Sanfilippo disease","volume":"286","author":"Lamanna","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0165","series-title":"Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0175","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199610033351405","article-title":"Clinical and biochemical manifestations of hyaluronidase deficiency","volume":"335","author":"Natowicz","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0180","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1073\/pnas.96.11.6296","article-title":"Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX","volume":"96","author":"Triggs-Raine","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157488906775245282","article-title":"Miglustat: substrate reduction therapy for lysosomal storage disorders associated with primary central nervous system involvement","volume":"1","author":"Pastores","year":"2006","journal-title":"Recent. Pat. CNS Drug Discov."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-1-4939-1154-7_22","article-title":"Ganglioside storage diseases: on the road to management","volume":"9","author":"Seyfried","year":"2014","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0195","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1194\/jlr.M400411-JLR200","article-title":"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice","volume":"46","author":"Kasperzyk","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/368584","article-title":"Hyaluronan synthesis, catabolism, and signaling in neurodegenerative diseases","volume":"2015","author":"Sherman","year":"2015","journal-title":"Int. J. Cell. Biol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.22484","article-title":"White matter lesions defined by diffusion tensor imaging in older adults","volume":"70","author":"Back","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00005072-196504000-00004","article-title":"Chemical studies on Alzheimer\u2019s disease","volume":"24","author":"Suzuki","year":"1965","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0215","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1471-4159.1988.tb01135.x","article-title":"Glycosaminoglycans in cortical autopsy samples from Alzheimer brain","volume":"51","author":"Jenkins","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0220","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10408447509164014","article-title":"Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine","volume":"4","author":"L\u00fcllmann","year":"1975","journal-title":"CRC Crit. Rev. Toxicol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0230","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"L\u00fcllmann","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0235","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.febslet.2009.10.021","article-title":"Lysosomal degradation of membrane lipids","volume":"584","author":"Kolter","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0240","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jps.21197","article-title":"A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams","volume":"97","author":"Nonoyama","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0245","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1021\/bi00344a031","article-title":"Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1","volume":"24","author":"Kubo","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0250","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/dmd.112.050054","article-title":"Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)","volume":"41","author":"Kazmi","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10565-012-9212-3","article-title":"Cytoplasmic vacuolization during exposure to drugs and other substances","volume":"28","author":"Aki","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0260","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0006-2952(88)90130-X","article-title":"Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases","volume":"37","author":"Mingeot-Leclercq","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0265","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0006-2952(92)90258-K","article-title":"Effect of substrate organization on the activity and on the mechanism of gentamicin-induced inhibition of rat liver lysosomal phospholipase A1","volume":"43","author":"Piret","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(96)00552-3","article-title":"Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity","volume":"314","author":"Van Bambeke","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0275","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1016\/j.febslet.2006.07.071","article-title":"New insights on the use of desipramine as an inhibitor for acid ceramidase","volume":"580","author":"Elojeimy","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00223481","article-title":"Amiodarone-an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine","volume":"76","author":"Shaikh","year":"1987","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/187231207779814292","article-title":"A role for lysosomal phospholipase A2 in drug induced phospholipidosis","volume":"1","author":"Abe","year":"2007","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0290","first-page":"2582","article-title":"Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs","volume":"43","author":"Hostetler","year":"1984","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0295","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2131\/jts.37.261","article-title":"In vitro validation of drug-induced phospholipidosis","volume":"37","author":"Park","year":"2012","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0300","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0305","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1016\/S0021-9258(17)37705-0","article-title":"Processing of human acid sphingomyelinase in normal and I-cell fibroblasts","volume":"269","author":"Hurwitz","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0310","first-page":"218","article-title":"Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures","volume":"35","author":"Albouz","year":"1981","journal-title":"Biomedicine"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0315","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1172\/JCI5307","article-title":"Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier","volume":"104","author":"Jensen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0320","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00294-007-0151-0","article-title":"Membrane stress is coupled to a rapid translational control of gene expression in chlorpromazine-treated cells","volume":"52","author":"De Filippi","year":"2007","journal-title":"Curr. Genet."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03191315","article-title":"Incorporation of chlorpromazine into bilayer liposomes for protection against microsomal metabolism and liver absorption","volume":"13","author":"Schwendener","year":"1988","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0330","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1139\/y87-064","article-title":"Effect of chlorpromazine on the synthesis, hydrolysis, and transfer of microsomal cytidine liponucleotides and mitochondrial polyglycerophosphatides","volume":"65","author":"Stuhne-Sekalec","year":"1987","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0335","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1099\/vir.0.18883-0","article-title":"Interference in japanese encephalitis virus infection of vero cells by a cationic amphiphilic drug, chlorpromazine","volume":"84","author":"Nawa","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0340","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ceb.2004.06.001","article-title":"Cargo recognition during clathrin-mediated endocytosis: a team effort","volume":"16","author":"Sorkin","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bpc.2005.05.002","article-title":"Importance of polyunsaturated acyl chains in chlorpromazine interaction with phosphatidylserines: a 13C and 31P solid-state NMR study","volume":"117","author":"Chen","year":"2005","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0350","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbalip.2004.01.004","article-title":"Chlorpromazine interaction with phosphatidylserines: a (13)C and (31)P solid-state NMR study","volume":"1682","author":"Underhaug Gjerde","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.04.007_bb0355","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/oxfordjournals.jbchem.a135438","article-title":"Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs","volume":"98","author":"Yoshida","year":"1985","journal-title":"J. Biochem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0360","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/S0021-9258(19)70769-8","article-title":"Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4\u2032-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane","volume":"255","author":"Matsuzawa","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0365","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0006-2952(80)90222-1","article-title":"The effects of ammonium ions and chloroquine on uptake and degradation of 125I-labeled asialo-fetuin in isolated rat hepatocytes","volume":"29","author":"Berg","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0370","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/0006-2952(79)90586-0","article-title":"Chloroquine reduces the number of asialo-glycoprotein receptors in the hepatocyte plasma membrane","volume":"28","author":"Tolleshaug","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0375","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-6997(25)00049-3","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","author":"Kodavanti","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0380","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/0006-2952(84)90286-7","article-title":"Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A","volume":"33","author":"Pappu","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0385","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/j.1471-4159.1971.tb05063.x","article-title":"Age-dependent variations of the human N-acetyl-\u03b2-D-hexosaminidases","volume":"18","author":"Harzer","year":"1971","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0390","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10719-008-9137-5","article-title":"Hexosaminidase assays","volume":"26","author":"Wendeler","year":"2009","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0395","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-4939-8552-4_18","article-title":"Methods for assay of ganglioside catabolic enzymes","volume":"1804","author":"Loberto","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymgme.2019.04.007_bb0400","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12035-013-8605-5","article-title":"Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on beta-hexosaminidase activity in Sandhoff fibroblasts","volume":"50","author":"Chiricozzi","year":"2014","journal-title":"Mol. Neurobiol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219300344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219300344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:30Z","timestamp":1761089130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219300344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":80,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1096719219300344"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.04.007","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}